PL2249804T3 - Produkty do implantacji zawierające nanocząsteczki - Google Patents

Produkty do implantacji zawierające nanocząsteczki

Info

Publication number
PL2249804T3
PL2249804T3 PL09711314T PL09711314T PL2249804T3 PL 2249804 T3 PL2249804 T3 PL 2249804T3 PL 09711314 T PL09711314 T PL 09711314T PL 09711314 T PL09711314 T PL 09711314T PL 2249804 T3 PL2249804 T3 PL 2249804T3
Authority
PL
Poland
Prior art keywords
nanoparticles
implantable products
implantable
products
Prior art date
Application number
PL09711314T
Other languages
English (en)
Inventor
Burghard Thiesen
Andreas Jordan
Original Assignee
Magforce Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magforce Ag filed Critical Magforce Ag
Publication of PL2249804T3 publication Critical patent/PL2249804T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Composite Materials (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
PL09711314T 2008-02-11 2009-02-11 Produkty do implantacji zawierające nanocząsteczki PL2249804T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008008522A DE102008008522A1 (de) 2008-02-11 2008-02-11 Implantierbare Nanopartikel-enthaltende Produkte
US7108408P 2008-04-11 2008-04-11
EP09711314.6A EP2249804B1 (de) 2008-02-11 2009-02-11 Implantierbare nanopartikel-enthaltende produkte

Publications (1)

Publication Number Publication Date
PL2249804T3 true PL2249804T3 (pl) 2017-07-31

Family

ID=40847365

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09711314T PL2249804T3 (pl) 2008-02-11 2009-02-11 Produkty do implantacji zawierające nanocząsteczki

Country Status (18)

Country Link
US (1) US20110223255A1 (pl)
EP (1) EP2249804B1 (pl)
JP (1) JP5649455B2 (pl)
KR (1) KR101581973B1 (pl)
CN (1) CN101938993A (pl)
AU (1) AU2009214533B2 (pl)
BR (1) BRPI0906611A8 (pl)
CA (1) CA2712832C (pl)
DE (2) DE102008008522A1 (pl)
DK (1) DK2249804T3 (pl)
ES (1) ES2619509T3 (pl)
IL (1) IL207137A (pl)
MX (1) MX2010008806A (pl)
PL (1) PL2249804T3 (pl)
PT (1) PT2249804T (pl)
RU (1) RU2524644C2 (pl)
SG (1) SG188146A1 (pl)
WO (1) WO2009100716A2 (pl)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5539649B2 (ja) 2005-12-13 2014-07-02 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 細胞移植のための足場
JP5690143B2 (ja) 2008-02-13 2015-03-25 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 持続的細胞プログラミング装置
US20110165255A1 (en) * 2008-09-04 2011-07-07 Takeshi Kobayashi Malignant tumor heat therapy kit comprising anti-regulatory t cell antibody and magnetic fine particles and heat therapy method thereof
JP5463531B2 (ja) * 2009-07-22 2014-04-09 国立大学法人 東京大学 Ｐｈｄ２発現抑制物質搭載ポリイオンコンプレックス
CA2768552A1 (en) 2009-07-31 2011-02-03 President And Fellows Of Harvard College Programming of cells for tolerogenic therapies
EP2322142B1 (de) * 2009-11-12 2016-07-27 Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH Biokompatible, magnetische Nanopartikel zur Behandlung von Glioblastomen
DE102009058769A1 (de) * 2009-12-16 2011-06-22 MagForce Nanotechnologies AG, 10589 Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
WO2012001577A1 (en) * 2010-06-29 2012-01-05 Koninklijke Philips Electronics N.V. Synthesis and use of iron oleate
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
ES2780930T3 (es) 2010-08-27 2020-08-27 Sebacia Inc Composiciones y métodos para termomodulación dirigida
LT2624873T (lt) 2010-10-06 2020-03-10 President And Fellows Of Harvard College Įšvirkščiami, poras sudarantys hidrogeliai, skirti medžiagų pagrindo ląstelių terapijai
US8944067B2 (en) * 2010-12-15 2015-02-03 Kci Licensing, Inc. Targeted delivery of magnetically tagged active agents in combination with negative pressure wound therapy
US9764157B2 (en) 2011-01-17 2017-09-19 University Of Utah Research Foundation Methods, systems, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles
WO2012177296A1 (en) 2011-01-17 2012-12-27 University Of Utah Research Foundation Apparatus and methods for reducing frequency or severity of photophobic responses or modulating circadian cycles
US10359552B2 (en) 2011-01-17 2019-07-23 University Of Utah Research Foundation Methods, systems, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles
ES2561752T3 (es) 2011-03-10 2016-02-29 Magforce Ag Herramienta para simulación asistida por ordenador para proporcionar asistencia en la planificación de termoterapia
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
ES2878089T3 (es) 2011-04-28 2021-11-18 Harvard College Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva
EP2704666A4 (en) * 2011-05-06 2014-12-17 Mitchel J Doktycz ACTIVE SUBSTANCES TO PREVENT AND PREVENT POLLUTION OF SURFACES
EP2714073B1 (en) 2011-06-03 2021-03-10 President and Fellows of Harvard College In situ antigen-generating cancer vaccine
CN102379762B (zh) * 2011-08-02 2015-03-25 上海微创医疗器械（集团）有限公司 一种带凹槽的生物可降解支架及其制备方法
ES2807209T3 (es) 2011-08-10 2021-02-22 Magforce Ag Método para fabricar nanopartículas magnéticas aglomerantes recubiertas con alcoxisilano
MX362089B (es) 2011-12-16 2019-01-07 Nanobiotix Nanopartículas que comprenden materiales metálicos y óxido de hafnio, preparación y usos de los mismos.
PL2838515T3 (pl) 2012-04-16 2020-06-29 President And Fellows Of Harvard College Kompozycje mezoporowatego krzemu do modulowania odpowiedzi odpornościowych
WO2014058904A1 (en) 2012-10-11 2014-04-17 Nanocomposix, Inc. Silver nanoplate compositions and methods
WO2014085651A1 (en) * 2012-11-29 2014-06-05 The Johns Hopkins University A process for making iron oxide nanoparticle preparations for cancer hyperthermia
WO2014121224A2 (en) * 2013-02-01 2014-08-07 The Trustees Of Dartmouth College Biodegradable iron oxide nanoparticle gel for tumor bed therapy
WO2014124322A1 (en) 2013-02-08 2014-08-14 University Of Louisville Research Foundation, Inc. Nanoparticles for drug delivery
CN103203903A (zh) * 2013-03-25 2013-07-17 海龙核材科技（江苏）有限公司 一种电场磁场下响应的传感材料及其制备方法
AU2014276932B2 (en) * 2013-06-04 2017-04-13 Fumedica Ag Cytotoxic substance for use in combination with radiotherapy in cancer treatment
AU2014283217A1 (en) * 2013-06-20 2015-12-24 Nanobiotix Compositions and methods for use in medical diagnosis
EP2823858A1 (en) 2013-07-12 2015-01-14 Brossel, Rémy System generating a constraint field, and medical device implementing the same
WO2015020936A1 (en) 2013-08-06 2015-02-12 Ut-Battelle, Llc Local thermal actuation of material surfaces via micro- and nanowire heating for the prevention of cellular attachment and biological fouling
US10281627B2 (en) 2013-11-15 2019-05-07 University Of Utah Research Foundation Nanoparticle light filtering method and apparatus
US10234608B2 (en) 2013-11-15 2019-03-19 University Of Utah Research Foundation Nanoparticle light filtering method and apparatus
CN103752849B (zh) * 2014-02-13 2016-02-24 华东理工大学 制备稳定纳米银的方法
US9814631B2 (en) * 2014-03-03 2017-11-14 Sambhu Choudhury Container for surgical absorbent articles
EP3131627A1 (en) 2014-04-17 2017-02-22 Boston Scientific Scimed, Inc. Devices and methods for therapeutic heat treatment
EP3137105A4 (en) 2014-04-30 2017-12-27 President and Fellows of Harvard College Combination vaccine devices and methods of killing cancer cells
CN103989552B (zh) * 2014-05-07 2015-10-28 江苏达胜伦比亚生物科技有限公司 一种医用水凝胶凉贴
CZ27466U1 (cs) * 2014-08-21 2014-11-10 Univerzita Tomáše Bati ve Zlíně Biomateriál na bázi hydrogelu citlivý na magnetické podněty
RU2616258C2 (ru) * 2014-11-10 2017-04-13 федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (государственный университет)" Способ получения полимерных наночастиц низкосиалированного эритропоэтина с высокой степенью сорбции для лечения неврологических заболеваний
HK1247861A1 (zh) 2015-01-30 2018-10-05 President And Fellows Of Harvard College 用於癌症治疗的肿瘤周围和肿瘤内部材料
EP3280464A4 (en) 2015-04-10 2018-09-26 President and Fellows of Harvard College Immune cell trapping devices and methods for making and using the same
HK1246160A1 (zh) 2015-05-28 2018-09-07 Nanobiotix 用作治疗性疫苗的纳米粒子
CN108463256B (zh) * 2015-09-04 2021-04-16 约翰内斯堡威特沃特斯兰德大学 生物可降解的植入物
WO2017062565A1 (en) 2015-10-07 2017-04-13 Boston Scientific Scimed, Inc. Mixture of lafesih magnetic nanoparticles with different curie temperatures to improve inductive heating efficiency for hyperthermia therapy
RU167739U1 (ru) * 2015-12-02 2017-01-10 Федеральное государственное бюджетное учреждение науки Красноярский научный центр Сибирского отделения Российской академии наук (ФГБУН КНЦ СО РАН) Нанодиски для разрушения опухолевых клеток
WO2017136837A1 (en) 2016-02-06 2017-08-10 President And Fellows Of Harvard College Recapitulating the hematopoietic niche to reconstitute immunity
FI3484448T3 (fi) 2016-07-13 2025-06-16 Harvard College Antigeenia esitteleviä solumimeettisiä tukirakenteita ja menetelmiä niiden valmistamiseksi ja käyttämiseksi
CN110418651A (zh) 2016-08-02 2019-11-05 哈佛学院院长等 用于调节免疫应答的生物材料
JP6968887B2 (ja) * 2016-09-08 2021-11-17 シェーファー・カーク・ゲーエムベーハー・ウント・コンパニー・カーゲーSchaefer Kalk Gmbh & Co. Kg 微細構造粒子を有するカルシウム塩含有複合粉末
EP3305334A1 (en) * 2016-10-06 2018-04-11 Universitätsklinikum Jena Magnetic composition and medical material for stimulating vascularisation in internal or external wound of the body
WO2018105779A1 (ko) * 2016-12-07 2018-06-14 서울대학교산학협력단 바이오 패치, 바이오 히터, 바이오 센서, 및 바이오 전자 패치 장치
CZ307237B6 (cs) * 2016-12-16 2018-04-18 Synthesia, A. S. Supramolekulární komplex oxycelulózové matrice s taxolovým derivátem s postupným uvolňováním taxolového derivátu a jeho použití
US12396951B2 (en) 2016-12-27 2025-08-26 Upexmed Co. Ltd. Prevention of local tumor recurrence following surgery using sustainedand/or delayed release of medicaments contained in micro-particles
WO2018125862A1 (en) * 2016-12-27 2018-07-05 Soon Kap Hahn Prevention of local tumor recurrence following surgery using sustained and/or delayed release of medicaments contained in micro-particles
DE102017214576A1 (de) * 2017-08-21 2019-02-21 Universität Bielefeld Anorganisch-organischer Nanokomposit mit zellbiologischer und sensorischer Aktivität
RU181003U1 (ru) * 2017-11-14 2018-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Пластинчатый дентальный имплантат для многопозиционного протезирования
RU181004U1 (ru) * 2017-11-14 2018-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Пластинчатый дентальный имплантат для многопозиционного протезирования
RU181002U1 (ru) * 2017-12-25 2018-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Пластинчатый дентальный имплантат для многопозиционного протезирования
KR102200787B1 (ko) * 2017-12-29 2021-01-12 한경대학교 산학협력단 나노셀룰로오스를 이용한 습윤성 탄력붕대
CN108912628A (zh) * 2018-05-31 2018-11-30 苏州乔纳森新材料科技有限公司 一种插管用抗菌纳米材料的制备方法
WO2020061129A1 (en) 2018-09-19 2020-03-26 President And Fellows Of Harvard College Compositions and methods for labeling and modulation of cells in vitro and in vivo
RU189268U1 (ru) * 2019-03-22 2019-05-17 Артем Олегович Бахметьев Акупунктурная игла
RU189308U1 (ru) * 2019-03-22 2019-05-21 Артем Олегович Бахметьев Трансдермальный пластырь
KR102372213B1 (ko) * 2019-09-09 2022-03-08 한국화학연구원 히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름
WO2021061837A1 (en) 2019-09-23 2021-04-01 President And Fellows Of Harvard College Biomaterial-based antigen free vaccine and the use thereof
WO2021152136A1 (en) 2020-01-31 2021-08-05 Magforce Ag Paste comprising magnetic alkoxysilane-coated metal containing nanoparticles
CN111921003B (zh) * 2020-09-04 2022-06-03 东南大学 一种磁响应热疗可控降解栓塞微球及其制备方法与应用
CN112972778B (zh) * 2021-02-05 2022-05-27 华中科技大学 一种人工膀胱铁磁复合物及其制备方法
CN112972779B (zh) * 2021-02-05 2022-07-12 武汉磁济科技有限公司 一种植入式柔性磁响应人工膀胱基体及其制造方法
CN112933288B (zh) * 2021-02-08 2022-02-22 四川大学 兼具止血和术后抗肿瘤功能的交联止血海绵及其制备方法
US20230061188A1 (en) * 2021-08-30 2023-03-02 Apple Inc. Enhanced mems sensor embedded heater
DE102022115394A1 (de) 2022-06-21 2023-12-21 Rheinisch-Westfälische Technische Hochschule (Rwth) Aachen Implantat und Anordnung aufweisend eine Strahlungsquelle und ein Implantat

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31064A (en) * 1990-09-07 1998-02-05 Nycomed As Of Nycoveten Polymers containing diester units.
US5411730A (en) 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
DE4428851C2 (de) 1994-08-04 2000-05-04 Diagnostikforschung Inst Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
DE19614136A1 (de) 1996-04-10 1997-10-16 Inst Neue Mat Gemein Gmbh Verfahren zur Herstellung agglomeratfreier nanoskaliger Eisenoxidteilchen mit hydrolysebeständigem Überzug
JPH10328314A (ja) * 1997-06-02 1998-12-15 Nippon Electric Glass Co Ltd 温熱治療用セメント材料及び温熱治療用インプラント材
JPH10337335A (ja) * 1997-06-06 1998-12-22 Nippon Electric Glass Co Ltd 温熱治療用インプラント材
DE19726282A1 (de) 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
US6267782B1 (en) * 1997-11-20 2001-07-31 St. Jude Medical, Inc. Medical article with adhered antimicrobial metal
ATE463342T1 (de) * 1999-07-16 2010-04-15 Univ Wm Marsh Rice Temperaturabhängiges polymer/nanohüllen-komposite für photothermische modulierte arzneimittelabgabe
DE10059151C2 (de) 2000-11-29 2003-10-16 Christoph Alexiou Magnetische Partikel zur zielgerichteten regionalen Therapie und Verwendung derselben
US6527693B2 (en) * 2001-01-30 2003-03-04 Implant Sciences Corporation Methods and implants for providing radiation to a patient
US20060057192A1 (en) 2001-09-28 2006-03-16 Kane Patrick D Localized non-invasive biological modulation system
DE10164309A1 (de) * 2001-12-28 2003-07-10 Fraunhofer Ges Forschung Verbesserte strukturiert-funktionale Bindematrices für Biomoleküle
US7101394B2 (en) * 2002-05-02 2006-09-05 Boston Scientific Scimed, Inc. Energetically-controlled delivery of biologically active material from an implanted medical device
WO2004034876A2 (en) * 2002-10-15 2004-04-29 Ferx Incorporated Magnetically guided particles for radiative therapies
ITTO20020994A1 (it) * 2002-11-15 2004-05-16 Torino Politecnico Materiali magnetici biocompatibili per il trattamento del cancro mediante ipertermia, e processi per la loro realizzazione.
DE10350248A1 (de) 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
WO2005065282A2 (en) 2003-12-31 2005-07-21 The Regents Of The University Of California Remote magnetically induced treatment of cancer
CA2553647A1 (en) 2004-01-20 2005-08-04 Alnis Biosciences, Inc. Articles comprising magnetic material and bioactive agents
WO2006015317A2 (en) * 2004-07-30 2006-02-09 Acrymed, Inc. Antimicrobial devices and compositions
CN101431983A (zh) * 2004-09-28 2009-05-13 香港科技大学 作为生物材料的多功能的超分子水凝胶
DE102005016873A1 (de) 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
US20090081122A1 (en) * 2005-05-23 2009-03-26 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
FR2889449B1 (fr) 2005-08-05 2011-06-10 Khorionyx Preparations implantables
DE102005039579B4 (de) 2005-08-19 2022-06-30 Magforce Ag Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
US20090098033A1 (en) * 2006-02-10 2009-04-16 Kun Lian Carbon-Encased Metal Nanoparticles and Sponges, Methods of Synthesis, and Methods of Use
AU2008206064A1 (en) * 2007-01-19 2008-07-24 Triton Biosystems, Inc. Thermotherapy susceptors and methods of using same

Also Published As

Publication number Publication date
IL207137A (en) 2015-02-26
RU2010136311A (ru) 2012-03-20
PT2249804T (pt) 2017-03-20
BRPI0906611A8 (pt) 2019-01-29
AU2009214533A1 (en) 2009-08-20
JP2011511684A (ja) 2011-04-14
US20110223255A1 (en) 2011-09-15
RU2524644C2 (ru) 2014-07-27
EP2249804A2 (de) 2010-11-17
IL207137A0 (en) 2010-12-30
ES2619509T3 (es) 2017-06-26
EP2249804B1 (de) 2016-12-14
WO2009100716A2 (de) 2009-08-20
DE102008008522A1 (de) 2009-08-13
SG188146A1 (en) 2013-03-28
WO2009100716A3 (de) 2010-09-23
CA2712832A1 (en) 2009-08-20
AU2009214533B2 (en) 2015-01-29
MX2010008806A (es) 2010-12-21
BRPI0906611A2 (pt) 2015-07-14
CN101938993A (zh) 2011-01-05
DK2249804T3 (en) 2017-02-27
KR20100117602A (ko) 2010-11-03
DE112009000905A5 (de) 2011-01-20
JP5649455B2 (ja) 2015-01-07
KR101581973B1 (ko) 2015-12-31
CA2712832C (en) 2016-05-17

Similar Documents

Publication Publication Date Title
IL207137A0 (en) Implantable products comprising nanoparticles
EP2323947A4 (en) DISPERSABLE NANOPARTICLES IN WATER
ZA201005524B (en) Delivery particle
ZA201006260B (en) Delivery particle
ZA201100622B (en) Delivery particle
GB0802634D0 (en) Catheter
GB0802489D0 (en) Product
EP2371415A4 (en) CATHETER
GB0802116D0 (en) Treatment
GB2456425B (en) Catheter
GB0823472D0 (en) Product
GB0816501D0 (en) Photo-ionic pacemakers
GB0801643D0 (en) Product
GB0811992D0 (en) Treatment
GB0803054D0 (en) Medicament
GB0811170D0 (en) Nanoparticles
HU0800419D0 (en) Catheter
GB0819893D0 (en) Catheter
GB0820972D0 (en) Treatment
ZA201103081B (en) Product
GB0805912D0 (en) Treatment
ZA201004935B (en) Implantable products comprising nanoparticles
GB0816772D0 (en) Medical product
GB2466523B (en) Medical Product Manufacture
GB0815308D0 (en) Nanoparticles